As per SNS Insider Research, The Global Syndromic Multiplex Diagnostics Market Growth is Driven by Advancements in Molecular Diagnostics, Rising Burden of Infectious Diseases and Growing Demand for Rapid, Accurate Pathogen Detection.
Austin, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) — Syndromic Multiplex Diagnostics Market Size & Growth Analysis:
According to SNS Insider, The global Syndromic Multiplex Diagnostics Market was valued at USD 2.87 billion in 2024 and is expected to reach USD 4.13 billion by 2032, growing at a CAGR of 4.71% during the forecast period of 2025-2032. Market growth is driven by rising demand for rapid, accurate detection of infectious diseases and increased adoption of multiplex molecular diagnostic technologies across clinical settings.
The U.S. syndromic multiplex diagnostics market was valued at USD 0.89 billion in 2024 and is projected to reach USD 1.25 billion by 2032, expanding at a CAGR of 4.50%. Strong healthcare infrastructure, growing awareness of early diagnosis, and continued innovation in diagnostic platforms are supporting sustained market expansion in the region.
Get a Sample Report of Syndromic Multiplex Diagnostics Market: https://www.snsinsider.com/sample-request/8192
Increasing demand for rapid syndromic testing solutions in hospitals, clinical laboratories, and public health settings is significantly contributing to market growth. The rising prevalence of respiratory, gastrointestinal, bloodstream, and central nervous system infections has accelerated the adoption of multiplex diagnostic panels that enable simultaneous detection of multiple pathogens from a single sample. These solutions reduce time-to-diagnosis, support antimicrobial stewardship, and improve patient outcomes.
Major Players Analysis Listed in this Report are:
Syndromic Multiplex Diagnostics Market Report Scope
Due to the repeated usage of assay kits, cartridges, and the requirement of various consumables in high-throughput diagnostic workflows, the Reagents & Consumables segment held the dominating share of the syndromic multiplex diagnostics market in 2024, with 48.26%. The software & services segment is projected to be the fastest-growing segment during the forecast period, as there is an increasing adoption of cloud-based diagnostic platforms integrated with AI-powered analytics.
By Syndrome/Disease Type
The respiratory infections segment dominated the syndromic multiplex diagnostics market share in 2024 with 34.12%, maintaining its lucrative position during the forecast period, owing to the high global burden of respiratory diseases such as influenza, COVID-19, respiratory syncytial virus (RSV), and pneumonia. During the forecast period, the gastrointestinal infections segment is expected to grow at the fastest pace due to the increasing incidence of foodborne diseases globally, traveler’s diarrhea, and hospital-acquired infections in both developed and developing regions.
By Technology
Due to its common practice in clinical settings and associated high sensitivity and short turnaround time for cost-effectiveness, the PCR-based segment of the syndromic multiplex diagnostics market accounted for the largest share by technology in 2024. During the forecast period, the NGS segment is anticipated to be the fastest-growing as it offers the deepest view of pathogen detection capability, including detection of rare, novel, or co-infecting agents, compared to the other methods.
By End-User
Due to the high throughput capabilities, specialized equipment, and skilled personnel available to support complex and large-scale testing workflows, the diagnostic laboratories segment was the leading end user in the syndromic multiplex diagnostics market in 2024. The hospitals & clinics segment is anticipated to be the fastest growing during the forecast years, due to the high adoption rate of point-of-care testing, and the growing need for rapid diagnostics in these acute care settings.
Need Any Customization Research on Syndromic Multiplex Diagnostics Market, Enquire Now: https://www.snsinsider.com/enquiry/8192
Key Syndromic Multiplex Diagnostics Market Segments
The syndromic multiplex diagnostics market, dominated by North America, with a 40.6% in 2024 characterized by developed healthcare structures, quick adoption of advanced diagnostic technologies, and the dominance of key market players.
The Asia Pacific region is expected to witness the highest growth during the forecast period, with 5.77% CAGR on account of booming healthcare expenditure, increasing diagnostic capacities, and rising incidents of infectious diseases.
Recent Developments:
Purchase Single User PDF of Syndromic Multiplex Diagnostics Market Report (20% Discount): https://www.snsinsider.com/checkout/8192
Exclusive Sections of the Report (The USPs):
Access Complete Report Details of Syndromic Multiplex Diagnostics Market Analysis & Outlook: https://www.snsinsider.com/reports/syndromic-multiplex-diagnostics-market-8192
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
